These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38891839)

  • 1. Deciphering the Complex Immunopathogenesis of Alopecia Areata.
    Šutić Udović I; Hlača N; Massari LP; Brajac I; Kaštelan M; Vičić M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
    Strazzulla LC; Wang EHC; Avila L; Lo Sicco K; Brinster N; Christiano AM; Shapiro J
    J Am Acad Dermatol; 2018 Jan; 78(1):1-12. PubMed ID: 29241771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
    Petukhova L; Duvic M; Hordinsky M; Norris D; Price V; Shimomura Y; Kim H; Singh P; Lee A; Chen WV; Meyer KC; Paus R; Jahoda CA; Amos CI; Gregersen PK; Christiano AM
    Nature; 2010 Jul; 466(7302):113-7. PubMed ID: 20596022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia areata: A multifactorial autoimmune condition.
    Simakou T; Butcher JP; Reid S; Henriquez FL
    J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-inflammatory Vδ1
    Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
    J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata: a review of disease pathogenesis.
    Rajabi F; Drake LA; Senna MM; Rezaei N
    Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair follicle immune privilege and its collapse in alopecia areata.
    Bertolini M; McElwee K; Gilhar A; Bulfone-Paus S; Paus R
    Exp Dermatol; 2020 Aug; 29(8):703-725. PubMed ID: 32682334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of alopecia areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.
    Ito T
    Clin Dev Immunol; 2013; 2013():348546. PubMed ID: 24151515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata.
    Bertolini M; Zilio F; Rossi A; Kleditzsch P; Emelianov VE; Gilhar A; Keren A; Meyer KC; Wang E; Funk W; McElwee K; Paus R
    PLoS One; 2014; 9(5):e94260. PubMed ID: 24832234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collapse and Restoration of Hair Follicle Immune Privilege Ex Vivo: A Model for Alopecia Areata.
    Fehrholz M; Bertolini M
    Methods Mol Biol; 2020; 2154():133-141. PubMed ID: 32314213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.
    Ito T; Ito N; Saatoff M; Hashizume H; Fukamizu H; Nickoloff BJ; Takigawa M; Paus R
    J Invest Dermatol; 2008 May; 128(5):1196-206. PubMed ID: 18160967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity.
    Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S
    Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse.
    Bertolini M; Pretzlaff M; Sulk M; Bähr M; Gherardini J; Uchida Y; Reibelt M; Kinori M; Rossi A; Bíró T; Paus R
    Br J Dermatol; 2016 Sep; 175(3):531-41. PubMed ID: 27059672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives.
    Paus R; Bertolini M
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S25-7. PubMed ID: 24326544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunogenetics of Alopecia areata.
    Rajabi F; Abdollahimajd F; Jabalameli N; Nassiri Kashani M; Firooz A
    Adv Exp Med Biol; 2022; 1367():19-59. PubMed ID: 35286691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.